What's changed in the economic impact of occupational radiation exposure
Key inputs that drive the economic model
| Parameter | 2018 Value | 2025 Value | Change | Source |
|---|---|---|---|---|
| Economic Valuations | ||||
| Value of Statistical Life (VSL) | $9,000,000 | $13,600,000 | +51% | HHS 2025 |
| Non-Fatal Cancer Cost | $200,000 | $250,000 | +25% | Inflation-adjusted |
| Physician MSD Cost | $45,000 | $94,285 | +109% | NSC 2023 |
| Support Staff MSD Cost | $12,000 | $47,316 | +294% | NSC 2023 |
| Workforce | ||||
| Interventional Cardiologists | 3,255 | 5,639 | +73% | AAMC 2023 |
| Interventional Radiologists | 3,358 | 3,358 | 0% | Placeholder |
| Electrophysiologists | 1,925 | 2,629 | +37% | ABIM 2025 |
| Nurses | 13,000 | 13,000 | 0% | Placeholder |
| Technicians | 11,300 | 11,300 | 0% | Placeholder |
| Total Workforce | 32,838 | 35,926 | +9% | |
| Clinical Data | ||||
| MSD Career Prevalence | 53% | 66% | Not comparable | 2018: an early SCAI survey (treated for neck or back pain); 2025: SCAI 2023 (musculoskeletal pain) |
| Radial Access Rate | 30% | 68% | +38 pts | SCAI 2022 |
Radial artery access for cardiac catheterization has increased from 20% to 68% of procedures since 2013—a major improvement for patient safety with fewer bleeding complications and reduced mortality. However, radial access positions the operator closer to the radiation source, potentially increasing scatter exposure to the left side of the head and body. Despite this shift to radial access, MSD prevalence has actually increased from 53% to 66%, suggesting the technique does not reduce the orthopedic burden from lead aprons.
| Category | Group | 2018 Cases | 2018 Cost | 2025 Cases | 2025 Cost | Change |
|---|---|---|---|---|---|---|
| Fatal Cancer | Physicians | 1.5 | $13,500,000 | 2.3 | $31,704,000 | +135% |
| Fatal Cancer | Nurses/Techs | 2.5 | $22,500,000 | 2.4 | $33,048,000 | +47% |
| Non-Fatal Cancer | Physicians | 1.5 | $300,000 | 2.3 | $582,500 | +94% |
| Non-Fatal Cancer | Nurses/Techs | 2.5 | $500,000 | 2.4 | $607,500 | +22% |
| MSDs | Physicians | 155 | $6,975,000 | 209 | $19,726,565 | +183% |
| MSDs | Nurses/Techs | 435 | $5,220,000 | 437 | $20,677,092 | +296% |
| TOTAL | $48,995,000 | $106,345,657 | +117% | |||
Note: preliminary 2025 values, shown with 2025 workforce and placeholder support staff counts, so this total differs from the 2025 estimate above. Actual totals may vary based on confirmed nurse/technician counts; the updated study now underway will set the final figures.
The federal VSL increased 51% from $9M to $13.6M, directly impacting fatal cancer valuations which account for 73% of total costs.
Spine injury and MSD costs have more than doubled since 2018, with support staff MSD costs up 294%.
Interventional cardiologists increased 73% and electrophysiologists 37%, expanding the at-risk population.
In the 2023 SCAI survey, 66% of interventional cardiologists reported musculoskeletal pain, a sign that current protective equipment still takes a toll.
Adjust parameters yourself to see how changes in workforce, risk factors, and economic valuations affect the total economic impact.
Launch Calculator